Gemeprost versus misoprostol for cervical priming before first-trimester abortion: A randomized controlled trial

Obstetrics and Gynecology

Volumn 101, Issue 4, 2003, Pages 722-725

  Ekerhovd, Erling ^a   Radulovic, N ^a   Norstrom A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GEMEPROST; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; NULLIPARA; OUTCOMES RESEARCH; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TONOMETER; UTERINE CERVIX DILATATION; VACUUM ASPIRATION;

EID: 0037380040     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02734-5     Document Type: Article

References (18)

1. MacKenzie I.Z., Fry A. Prostaglandin E2 pessaries to facilitate first trimester aspiration termination. Br J Obstet Gynaecol. 88:1981;1033-1037.
2. Schultz K.F., Grimes D.A., Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet. i:1983;1182-1184.
3. Grimes D.A., Schultz K.F., Cates W.J. Prevention of uterine perforation during curettage abortion. JAMA. 251:1984;2108-2111.
4. Molin A. Risk of damage to the cervix by dilatation for first trimester induced abortion by suction aspiration. Gynecol Obstet Invest. 35:1993;152-154.
5. Bugalho A., Bique C., Almeida L., Bergström S. Application of vaginal misoprostol before cervical dilatation to facilitate first-trimester pregnancy interruption. Obstet Gynecol. 83:1994;729-731.
6. Ngai S.W., Tang O.S., Lao T., Ho P.C., Ma H.K. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum Reprod. 10:1995;1220-1222.
7. Ficicioglu C., Tasdemir M., Masdemir S. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta Obstet Gynecol Scand. 75:1996;54-56.
8. Fong Y.F., Singh K., Prasad R.N. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol. 105:1998;413-417.
9. Singh K., Fong Y.F., Prasad R.N., Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 92:1998;795-798.
10. MacIsaac L., Grossman D., Balistreri E., Darney P. A randomized controlled trial of laminaria, oral misoprostol and vaginal misoprostol before abortion. Obstet Gynecol. 93:1999;766-770.
11. Singh K., Fong Y.F., Prasad R.N.V., Dong F. Vaginal misoprostol for pre-abortion cervical priming Is there an optimal evacuation time interval? Br J Obstet Gynaecol. 106:1999;266-269.
12. Singh K., Fong Y.F., Prasad R.N., Dong F. Evacuation interval after vaginal misoprostol for preabortion cervical priming A randomized trial . Obstet Gynecol. 94:1999;431-434.
13. El-Refaey H., Calder L., Wheatley D.N., Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet. 343:1994;1207-1209.
14. 1 methyl analogue misoprostol on the pregnant human uterus in the first trimester. Geburtshilfe Frauenheilkd. 47:1987;324-331.
15. Fisher J., Anthony G.S., McManus T.J., Coutts J.R., Calder A.A. Use of a force measuring instrument during cervical dilatation. J Med Eng Technol. 5:1981;194-195.
16. Gore S.M., Altman D.G. Statistics in practice. 1992;British Medical Association, London.:6-9.
17. Henry A.-M., Haukkamaa M. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption. Br J Obstet Gynaecol. 106:1999;540-543.
18. Bugalho A., Faundes A., Jamisse L., Usfa M., Maria E., Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 53:1996;243-246.